Riskpilot← Back to searchSign inGet full accessGYNEKOLOGEN AS
ASActiveOrg 999275877Johan Stangs Plass 1, 1767 HaldenMedical specialists activities · NACE 8622Est. 20122 employees
Revenue 2025
NOK 5,4M
+2% vs 2024
EBITDA margin
38.1%
+6% vs 2024
Equity ratio
81.5%
Financial strength
Net profit 2025
NOK 1,9M
+11% vs 2024
| Revenue | NOK 5,4M | +2% |
| EBITDA | NOK 2,1M | +6% |
| Net profit | NOK 1,9M | +11% |
| Total assets | NOK 9,4M | +15% |
| Equity | NOK 7,6M | +16% |
| Employees | 2 | — |
Legal name
GYNEKOLOGEN AS
Org number
999275877
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
19. desember 2012
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet og spesialistpraksis innenfor gynekologi og fødselshjelp
Address
Johan Stangs Plass 1, 1767 Halden
Phone
+4769213750
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 846 | 4 803 | 4 700 | 5 299 | 5 400 |
| Staff expenses | −1 039 | −940 | −1 506 | −1 330 | −1 643 |
| EBITDA | 2 030 | 2 083 | 1 957 | 1 937 | 2 060 |
| Depreciation & amort. | −14 | −2 | −7 | −7 | −8 |
| EBIT | 2 015 | 2 081 | 1 949 | 1 930 | 2 052 |
| Net financials | 33 | 31 | 136 | 277 | 384 |
| Profit before tax | 2 049 | 2 112 | 2 086 | 2 207 | 2 436 |
| Tax | 445 | 465 | 456 | 477 | 512 |
| Net profit | 1 603 | 1 647 | 1 629 | 1 729 | 1 924 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 568 | 6 435 | 7 239 | 8 151 | 9 380 |
| Equity | 4 126 | 4 902 | 5 712 | 6 591 | 7 644 |
| Long-term debt | 2 | 12 | 19 | 2 | 19 |
| Short-term debt | 1 440 | 1 521 | 1 509 | 1 559 | 1 717 |
| Total debt | 1 443 | 1 533 | 1 528 | 1 560 | 1 736 |
EBITDA margin
38.1%
This company
15.8%
Market median
+141% vs market
20212025
Equity ratio
81.5%
This company
38.2%
Market median
+113% vs market
20212025
Return on equity
25.2%
This company
18.4%
Market median
+37% vs market
20212025
Net profit margin
35.6%
This company
8.1%
Market median
+340% vs market
20212025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20212025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PF Deputy Member | Deputy Member | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GYNEKOLOGEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pål Francis Hansen | Deputy Member | 0 companies |
| Hanne Siri Synnestvedt | Chairman | 0 companies |